BGM Group Ltd. Class A Ordinary Shares (BGM)

Price$0.36

Favorite Metrics

Price vs S&P 500 (26W)-105.29%

Price vs S&P 500 (4W)-55.66%

Market Capitalization$59.42M

All Metrics

P/CF (Annual)109.18x

Book Value / Share (Quarterly)$1.85

P/TBV (Annual)1.01x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-23.97%

Cash Flow / Share (Quarterly)$-0.07

Price vs S&P 500 (YTD)-95.38%

Gross Margin (TTM)19.41%

Net Profit Margin (TTM)-10.13%

EPS (TTM)$-0.28

10-Day Avg Trading Volume0.17M

EPS Excl Extra (TTM)$-0.28

Revenue Growth (5Y)-11.45%

EPS (Annual)$-0.20

ROI (Annual)-3.38%

Gross Margin (Annual)16.39%

Net Profit Margin (5Y Avg)-1.04%

Cash / Share (Quarterly)$0.15

Revenue Growth QoQ (YoY)13.92%

ROA (Last FY)-2.72%

Revenue Growth TTM (YoY)-10.12%

EBITD / Share (TTM)$-0.01

ROE (5Y Avg)1.12%

Operating Margin (TTM)-7.91%

Cash Flow / Share (Annual)$-0.13

P/B Ratio0.33x

P/B Ratio (Quarterly)6.11x

Net Income / Employee (Annual)$-0

Net Interest Coverage (TTM)-0.28x

ROA (TTM)-2.09%

EPS Incl Extra (Annual)$-0.20

Current Ratio (Annual)3.39x

Quick Ratio (Quarterly)1.33x

3-Month Avg Trading Volume0.17M

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.81

P/S Ratio (Annual)2.37x

Asset Turnover (Annual)0.47x

52-Week High$17.17

Operating Margin (5Y Avg)1.83%

EPS Excl Extra (Annual)$-0.20

CapEx CAGR (5Y)16.29%

26-Week Price Return-96.54%

Quick Ratio (Annual)2.73x

13-Week Price Return-90.82%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.82x

Enterprise Value$51.37

Revenue / Share Growth (5Y)21.40%

Asset Turnover (TTM)0.21x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)4.18x

Pretax Margin (Annual)-8.52%

Cash / Share (Annual)$3.02

3-Month Return Std Dev163.03%

Gross Margin (5Y Avg)10.94%

Net Income / Employee (TTM)$-0

EBITDA CAGR (5Y)-38.02%

ROE (Last FY)-3.38%

Net Interest Coverage (Annual)-0.22x

EPS Basic Excl Extra (Annual)$-0.20

P/FCF (TTM)21.76x

Receivables Turnover (TTM)8.60x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.28

Receivables Turnover (Annual)14.26x

ROI (TTM)-2.40%

P/S Ratio (TTM)2.21x

Pretax Margin (5Y Avg)-1.13%

Revenue / Share (Annual)$3.47

Tangible BV / Share (Annual)$6.36

Year-to-Date Return-91.25%

5-Day Price Return-0.37%

EPS Normalized (Annual)$-0.20

ROA (5Y Avg)-0.31%

Net Profit Margin (Annual)-5.75%

Month-to-Date Return6.78%

EBITD / Share (Annual)$0.11

Operating Margin (Annual)-2.25%

ROI (5Y Avg)0.15%

EPS Basic Excl Extra (TTM)$-0.28

P/TBV (Quarterly)6.26x

P/B Ratio (Annual)0.90x

Inventory Turnover (TTM)3.21x

Pretax Margin (TTM)-28.31%

Book Value / Share (Annual)$7.12

Price vs S&P 500 (13W)-93.69%

Beta1.92x

P/FCF (Annual)6.33x

Revenue / Share (TTM)$0.85

ROE (TTM)-2.42%

52-Week Low$0.27

About

BGM Group Ltd manufactures pharmaceutical active ingredients and medical products through biopharmaceutical and bio-extraction operations. Its core revenue comes from oxytetracycline APIs, licorice preparations, and traditional Chinese medicine derivatives (TCMD), with secondary contributions from crude heparin sodium and specialty sausage casings. The company specializes in producing essential pharmaceutical intermediates for the healthcare industry.